{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T06:45:20Z","timestamp":1790232320693,"version":"4.1.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Celiac disease (CD) is an enteropathy triggered by the ingestion of gluten proteins in genetically predisposed individuals and characterized by excessive activation of effector immune cells and enhanced production of inflammatory cytokines. However, factors\/mechanisms that amplify the ongoing mucosal inflammation in CD are not fully understood. In this study, we assessed whether mammalian target of Rapamycin (mTOR), a pathway that combines intra- and extra-cellular signals and acts as a central regulator for the metabolism, growth, and function of immune and non-immune cells, sustains CD-associated immune response. Our findings indicate that expression of phosphorylated (p)\/active form of mTOR is increased in protein lysates of duodenal biopsy samples taken from patients with active CD (ACD) as compared to normal controls. In ACD, activation of mTOR occurs mainly in the epithelial compartment and associates with enhanced expression of p-4EBP, a downstream target of mTOR complex (mTORC)1, while expression of p-Rictor, a component of mTORC2, is not increased. Stimulation of mucosal explants of inactive CD patients with pepsin-trypsin-digested (PT)-gliadin or IFN-\u03b3\/IL-21, two cytokines produced in CD by gluten-specific T cells, increases p-4EBP expression. Consistently, blockade of such cytokines in cultures of ACD mucosal explants reduces p-4EBP. Finally, we show that inhibition of mTORC1 with rapamycin in ACD mucosal explants reduces p-4EBP and production of IL-15, a master cytokine produced by epithelial cells in this disorder. Our data suggest that ACD inflammation is marked by activation of mTORC1 in the epithelial compartment.<\/jats:p>","DOI":"10.1038\/s41598-020-67889-4","type":"journal-article","created":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T10:40:20Z","timestamp":1593600020000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["mTOR sustains inflammatory response in celiac disease"],"prefix":"10.1038","volume":"10","author":[{"given":"S.","family":"Sedda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Dinallo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Marafini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Franz\u00e8","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O. A.","family":"Paoluzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Izzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Giuffrida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0302-8645","authenticated-orcid":false,"given":"A.","family":"Di Sabatino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G. R.","family":"Corazza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Monteleone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,7,1]]},"reference":[{"key":"67889_CR1","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/j.immuni.2012.06.006","volume":"36","author":"B Meresse","year":"2012","unstructured":"Meresse, B., Malamut, G. & Cerf-Bensussan, N. Celiac disease: An immunological jigsaw. Immunity 36, 907\u2013919 (2012).","journal-title":"Immunity"},{"key":"67889_CR2","doi-asserted-by":"crossref","unstructured":"Marafini, I., Monteleone, I., Di Fusco, D., et al. TNF-\u03b1 producing innate lymphoid cells (ILCs) are increased in active celiac disease and contribute to promote intestinal atrophy in mice. PLoS One 10 (5), (2015)","DOI":"10.1371\/journal.pone.0126291"},{"issue":"4","key":"67889_CR3","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.4049\/jimmunol.0901919","volume":"184","author":"I Monteleone","year":"2010","unstructured":"Monteleone, I. et al. Characterization of IL-17A-producing cells in celiac disease mucosa. J. Immunol. 184(4), 2211\u20132218 (2010).","journal-title":"J. Immunol."},{"issue":"3","key":"67889_CR4","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1136\/gut.48.3.425","volume":"48","author":"G Monteleone","year":"2001","unstructured":"Monteleone, G. et al. Role of interferon alpha in promoting T helper cell type 1 responses in the small intestine in coeliac disease. Gut 48(3), 425\u2013429 (2001).","journal-title":"Gut"},{"issue":"8","key":"67889_CR5","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1002\/1521-4141(200108)31:8<2247::AID-IMMU2247>3.0.CO;2-4","volume":"31","author":"G Monteleone","year":"2001","unstructured":"Monteleone, G. et al. Interferon-alpha drives T cell-mediated immunopathology in the intestine. Eur. J. Immunol. 31(8), 2247\u20132255 (2001).","journal-title":"Eur. J. Immunol."},{"key":"67889_CR6","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1053\/gast.2000.18149","volume":"119","author":"L Maiuri","year":"2000","unstructured":"Maiuri, L. et al. Interleukin 15 mediates epithelial changes in celiac disease. Gastroenterology 119, 996\u20131006 (2000).","journal-title":"Gastroenterology"},{"key":"67889_CR7","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.immuni.2004.06.020","volume":"21","author":"B Meresse","year":"2004","unstructured":"Meresse, B. et al. Coordinated induction by IL15 of a TCR-independent NKG2D signaling pathway converts CTL into lymphokine-activated killer cells in celiac disease. Immunity 21, 357\u2013366 (2004).","journal-title":"Immunity"},{"key":"67889_CR8","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1038\/nri2670","volume":"9","author":"B Jabri","year":"2009","unstructured":"Jabri, B. & Sollid, L. M. Tissue-mediated control of immunopathology in coeliac disease. Nat. Rev. Immunol. 9, 858\u2013870 (2009).","journal-title":"Nat. Rev. Immunol."},{"issue":"5717","key":"67889_CR9","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1126\/science.1106442","volume":"307","author":"TT Macdonald","year":"2005","unstructured":"Macdonald, T. T. & Monteleone, G. Immunity, inflammation, and allergy in the gut. Science 307(5717), 1920\u20131925 (2005).","journal-title":"Science"},{"key":"67889_CR10","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/S0016-5085(98)70134-9","volume":"115","author":"EM Nilsen","year":"1998","unstructured":"Nilsen, E. M. et al. Gluten induces an intestinal cytokine response strongly dominated by interferon gamma in patients with celiac disease. Gastroenterology 115, 551\u2013563 (1998).","journal-title":"Gastroenterology"},{"key":"67889_CR11","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1136\/gut.50.2.186","volume":"50","author":"VM Salvati","year":"2002","unstructured":"Salvati, V. M. et al. Interleukin 18 and associated markers of T helper cell type 1 activity in coeliac disease. Gut 50, 186\u2013190 (2002).","journal-title":"Gut"},{"key":"67889_CR12","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1136\/gut.2007.129882","volume":"57","author":"D Fina","year":"2008","unstructured":"Fina, D. et al. Interleukin 21 contributes to the mucosal T helper cell type 1 response in coeliac disease. Gut 57, 887\u2013892 (2008).","journal-title":"Gut"},{"key":"67889_CR13","doi-asserted-by":"crossref","first-page":"15137","DOI":"10.1073\/pnas.261570598","volume":"98","author":"AA Lighvani","year":"2001","unstructured":"Lighvani, A. A. et al. T-bet is rapidly induced by interferon-gamma in lymphoid and myeloid cells. Proc. Natl. Acad. Sci. USA 98, 15137\u201315142 (2001).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"67889_CR14","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1038\/ni794","volume":"3","author":"M Afkarian","year":"2002","unstructured":"Afkarian, M. et al. T-bet is a STAT1-induced regulator of IL-12R expression in naive CD4+ T cells. Nat. Immunol. 3, 549\u2013557 (2002).","journal-title":"Nat. Immunol."},{"issue":"8","key":"67889_CR15","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1136\/gut.2003.030551","volume":"53","author":"I Monteleone","year":"2004","unstructured":"Monteleone, I. et al. Regulation of the T helper cell type 1 transcription factor T-bet in coeliac disease mucosa. Gut 53(8), 1090\u20131095 (2004).","journal-title":"Gut"},{"key":"67889_CR16","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.immuni.2009.09.002","volume":"31","author":"X Hu","year":"2009","unstructured":"Hu, X. & Ivashkiv, L. B. Cross-regulation of signaling pathways by interferon-gamma: Implications for immune responses and autoimmune diseases. Immunity 31, 539\u2013550 (2009).","journal-title":"Immunity"},{"key":"67889_CR17","doi-asserted-by":"crossref","first-page":"3600","DOI":"10.4049\/jimmunol.169.7.3600","volume":"169","author":"M Strengell","year":"2002","unstructured":"Strengell, M., Sareneva, T., Foster, D., Julkunen, I. & Matikainen, S. IL-21 up-regulates the expression of genes associated with innate immunity and Th1 response. J. Immunol. 169, 3600\u20133605 (2002).","journal-title":"J. Immunol."},{"key":"67889_CR18","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1136\/gut.2006.093187","volume":"55","author":"G Monteleone","year":"2006","unstructured":"Monteleone, G. et al. Control of matrix metalloproteinase production in human intestinal fibroblasts by interleukin 21. Gut 55, 1774\u20131780 (2006).","journal-title":"Gut"},{"key":"67889_CR19","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1053\/j.gastro.2006.09.053","volume":"132","author":"R Caruso","year":"2007","unstructured":"Caruso, R. et al. A functional role for interleukin-21 in promoting the synthesis of the T-cell chemoattractant, MIP-3alpha, by gut epithelial cells. Gastroenterology 132, 166\u2013175 (2007).","journal-title":"Gastroenterology"},{"key":"67889_CR20","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.immuni.2010.03.001","volume":"32","author":"P Nava","year":"2010","unstructured":"Nava, P. et al. Interferon-gamma regulates intestinal epithelial homeostasis through converging beta-catenin signaling pathways. Immunity 32, 392\u2013402 (2010).","journal-title":"Immunity"},{"key":"67889_CR21","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.immuni.2013.02.011","volume":"38","author":"CK Wan","year":"2013","unstructured":"Wan, C. K. et al. The cytokines IL-21 and GM-CSF have opposing regulatory roles in the apoptosis of conventional dendritic cells. Immunity 38, 514\u2013527 (2013).","journal-title":"Immunity"},{"key":"67889_CR22","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.ceb.2011.09.003","volume":"23","author":"E Dazert","year":"2011","unstructured":"Dazert, E. & Hall, M. N. mTOR signaling in disease. Curr. Opin. Cell Biol. 23, 744\u2013755 (2011).","journal-title":"Curr. Opin. Cell Biol."},{"key":"67889_CR23","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.coi.2010.08.010","volume":"22","author":"C Peter","year":"2010","unstructured":"Peter, C., Waldmann, H. & Cobbold, S. P. mTOR signalling and metabolic regulation of T cell differentiation. Curr. Opin. Immunol. 22, 655\u2013661 (2010).","journal-title":"Curr. Opin. Immunol."},{"key":"67889_CR24","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1042\/BST20130041","volume":"41","author":"JJ Howell","year":"2013","unstructured":"Howell, J. J., Ricoult, S. J., Ben-Sahra, I. & Manning, B. D. A growing role for mTOR in promoting anabolic metabolism. Biochem. Soc. Trans. 41, 906\u2013912 (2013).","journal-title":"Biochem. Soc. Trans."},{"key":"67889_CR25","doi-asserted-by":"crossref","first-page":"473","DOI":"10.4161\/15384101.2014.991572","volume":"14","author":"M Morita","year":"2015","unstructured":"Morita, M. et al. mTOR coordinates protein synthesis, mitochondrial activity and proliferation. Cell Cycle 14, 473\u2013480 (2015).","journal-title":"Cell Cycle"},{"key":"67889_CR26","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.it.2014.11.005","volume":"36","author":"KN Pollizzi","year":"2015","unstructured":"Pollizzi, K. N. & Powell, J. D. Regulation of T cells by mTOR: The known knowns and the known unknowns. Trends. Immunol. 36, 13\u201320 (2015).","journal-title":"Trends. Immunol."},{"key":"67889_CR27","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.cell.2014.01.057","volume":"156","author":"D Benjamin","year":"2014","unstructured":"Benjamin, D. & Hall, M. N. mTORC1: Turning off is just as important as turning on. Cell 156, 627\u2013628 (2014).","journal-title":"Cell"},{"key":"67889_CR28","doi-asserted-by":"crossref","first-page":"409","DOI":"10.2174\/138920310791824093","volume":"11","author":"H Zhou","year":"2010","unstructured":"Zhou, H. & Huang, S. The complexes of mammalian target of rapamycin. Curr. Protein Pept. Sci. 11, 409\u2013424 (2010).","journal-title":"Curr. Protein Pept. Sci."},{"key":"67889_CR29","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.cell.2012.03.017","volume":"149","author":"M Laplante","year":"2012","unstructured":"Laplante, M. & Sabatini, D. M. mTOR signaling in growth control and disease. Cell 149, 274\u2013293 (2012).","journal-title":"Cell"},{"key":"67889_CR30","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1002\/jcp.24525","volume":"229","author":"H Yang","year":"2014","unstructured":"Yang, H. et al. Modulation of TSC-mTOR signaling on immune cells in immunity and autoimmunity. J. Cell. Physiol. 229, 17\u201326 (2014).","journal-title":"J. Cell. Physiol."},{"key":"67889_CR31","doi-asserted-by":"crossref","first-page":"2834","DOI":"10.1038\/ncomms3834","volume":"4","author":"V Byles","year":"2013","unstructured":"Byles, V. et al. The TSC-mTOR pathway regulates macrophage polarization. Nat. Commun. 4, 2834 (2013).","journal-title":"Nat. Commun."},{"key":"67889_CR32","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1111\/1751-2980.12095","volume":"14","author":"SH Long","year":"2013","unstructured":"Long, S. H. et al. Activation of PI3K\/Akt\/mTOR signaling pathway triggered by PTEN downregulation in the pathogenesis of Crohn\u2019s disease. J. Dig. Dis. 14, 662\u2013669 (2013).","journal-title":"J. Dig. Dis."},{"key":"67889_CR33","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1038\/s41385-018-0018-3","volume":"11","author":"X Lin","year":"2018","unstructured":"Lin, X. et al. Colonic epithelial mTORC1 promotes ulcerative colitis through COX-2-mediated Th17 responses. Mucosal Immunol. 11, 1663\u20131673 (2018).","journal-title":"Mucosal Immunol."},{"key":"67889_CR34","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.cmet.2017.11.004","volume":"27","author":"A Ardestani","year":"2018","unstructured":"Ardestani, A., Lupse, B., Kido, Y., Leibowitz, G. & Maedler, K. mTORC1 signaling: A double-edged sword in diabetic beta cells. Cell Metab. 27, 314\u2013331 (2018).","journal-title":"Cell Metab."},{"key":"67889_CR35","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1016\/j.jmb.2018.02.013","volume":"430","author":"T Yuan","year":"2018","unstructured":"Yuan, T., Lupse, B., Maedler, K. & Ardestani, A. mTORC2 signaling: A path for pancreatic beta cell\u2019s growth and function. J. Mol. Biol. 430, 904\u2013918 (2018).","journal-title":"J. Mol. Biol."},{"key":"67889_CR36","doi-asserted-by":"crossref","first-page":"e0185025","DOI":"10.1371\/journal.pone.0185025","volume":"12","author":"G Pietz","year":"2017","unstructured":"Pietz, G. et al. Immunopathology of childhood celiac disease\u2014Key role of intestinal epithelial cells. PLoS ONE 12, e0185025 (2017).","journal-title":"PLoS ONE"},{"key":"67889_CR37","doi-asserted-by":"crossref","first-page":"9394","DOI":"10.1073\/pnas.1511711112","volume":"112","author":"CK Wan","year":"2015","unstructured":"Wan, C. K. et al. Opposing roles of STAT1 and STAT3 in IL-21 function in CD4+ T cells. Proc. Natl. Acad. Sci. USA 112, 9394\u20139399 (2015).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"67889_CR38","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1136\/gut.2005.068684","volume":"55","author":"A Di Sabatino","year":"2006","unstructured":"Di Sabatino, A. et al. Epithelium derived interleukin 15 regulates intraepithelial lymphocyte Th1 cytokine production, cytotoxicity, and survival in coeliac disease. Gut 55, 469\u2013477 (2006).","journal-title":"Gut"},{"key":"67889_CR39","doi-asserted-by":"crossref","first-page":"e0180853","DOI":"10.1371\/journal.pone.0180853","volume":"12","author":"C Buerger","year":"2017","unstructured":"Buerger, C. et al. Inflammation dependent mTORC1 signaling interferes with the switch from keratinocyte proliferation to differentiation. PLoS ONE 12, e0180853 (2017).","journal-title":"PLoS ONE"},{"key":"67889_CR40","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1038\/nrrheum.2015.172","volume":"12","author":"A Perl","year":"2016","unstructured":"Perl, A. Activation of mTOR (mechanistic target of rapamycin) in rheumatic diseases. Nat. Rev. Rheumatol. 12, 169\u2013182 (2016).","journal-title":"Nat. Rev. Rheumatol."},{"key":"67889_CR41","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1007\/s00125-016-4188-9","volume":"60","author":"T Yuan","year":"2017","unstructured":"Yuan, T. et al. Reciprocal regulation of mTOR complexes in pancreatic islets from humans with type 2 diabetes. Diabetologia 60, 668\u2013678 (2017).","journal-title":"Diabetologia"},{"key":"67889_CR42","doi-asserted-by":"crossref","first-page":"e17039","DOI":"10.1371\/journal.pone.0017039","volume":"6","author":"MV Barone","year":"2011","unstructured":"Barone, M. V. et al. Gliadin-mediated proliferation and innate immune activation in celiac disease are due to alterations in vesicular trafficking. PLoS ONE 6, e17039 (2011).","journal-title":"PLoS ONE"},{"key":"67889_CR43","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.jnutbio.2017.10.017","volume":"54","author":"A Barilli","year":"2018","unstructured":"Barilli, A. et al. Gluten peptides drive healthy and celiac monocytes toward an M2-like polarization. J. Nutr. Biochem. 54, 11\u201317 (2018).","journal-title":"J. Nutr. Biochem."},{"key":"67889_CR44","doi-asserted-by":"crossref","first-page":"339","DOI":"10.4049\/jimmunol.1303356","volume":"195","author":"Y Guan","year":"2015","unstructured":"Guan, Y. et al. Repression of mammalian target of rapamycin complex 1 inhibits intestinal regeneration in acute inflammatory bowel disease models. J. Immunol. 195, 339\u2013346 (2015).","journal-title":"J. Immunol."},{"issue":"2","key":"67889_CR45","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1038\/mi.2012.65","volume":"6","author":"M Sarra","year":"2013","unstructured":"Sarra, M. et al. IL-15 positively regulates IL-21 production in celiac disease mucosa. Mucosal Immunol. 6(2), 244\u2013255 (2013).","journal-title":"Mucosal Immunol."},{"key":"67889_CR46","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1101\/gad.1662308","volume":"22","author":"HC Dan","year":"2008","unstructured":"Dan, H. C. et al. Akt-dependent regulation of NF-{kappa}B is controlled by mTOR and Raptor in association with IKK. Genes Dev. 22, 1490\u20131500 (2008).","journal-title":"Genes Dev."},{"key":"67889_CR47","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/s10238-016-0429-y","volume":"17","author":"M Sisto","year":"2017","unstructured":"Sisto, M., Lorusso, L. & Lisi, S. TLR2 signals via NF-kappaB to drive IL-15 production in salivary gland epithelial cells derived from patients with primary Sjogren\u2019s syndrome. Clin. Exp. Med. 17, 341\u2013350 (2017).","journal-title":"Clin. Exp. Med."},{"key":"67889_CR48","doi-asserted-by":"crossref","first-page":"4418","DOI":"10.4049\/jimmunol.160.9.4418","volume":"160","author":"RN Bamford","year":"1998","unstructured":"Bamford, R. N., DeFilippis, A. P., Azimi, N., Kurys, G. & Waldmann, T. A. The 5\u02b9 untranslated region, signal peptide, and the coding sequence of the carboxyl terminus of IL-15 participate in its multifaceted translational control. J. Immunol. 160, 4418\u20134426 (1998).","journal-title":"J. Immunol."},{"key":"67889_CR49","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1182\/blood.V97.1.14","volume":"97","author":"TA Fehniger","year":"2001","unstructured":"Fehniger, T. A. & Caligiuri, M. A. Interleukin 15: Biology and relevance to human disease. Blood 97, 14\u201332 (2001).","journal-title":"Blood"},{"key":"67889_CR50","doi-asserted-by":"crossref","first-page":"686984","DOI":"10.1155\/2014\/686984","volume":"2014","author":"M Showkat","year":"2014","unstructured":"Showkat, M., Beigh, M. A. & Andrabi, K. I. mTOR signaling in protein translation regulation: Implications in cancer genesis and therapeutic interventions. Mol. Biol. Int. 2014, 686984 (2014).","journal-title":"Mol. Biol. Int."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-67889-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-67889-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-67889-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,3]],"date-time":"2023-10-03T07:52:22Z","timestamp":1696319542000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-67889-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,1]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["67889"],"URL":"https:\/\/doi.org\/10.1038\/s41598-020-67889-4","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,1]]},"assertion":[{"value":"1 August 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 June 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Monteleone G has served as an advisory board member for ABBVIE. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"10798"}}